These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9275974)

  • 1. Iodinated contrast material in uroradiology. Choice of agent and management of complications.
    Cohan RH; Ellis JH
    Urol Clin North Am; 1997 Aug; 24(3):471-91. PubMed ID: 9275974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate Mild Reactions to CT with Iodinated Contrast Media: Strategy of Contrast Media Readministration without Corticosteroids.
    Park SJ; Kang DY; Sohn KH; Yoon SH; Lee W; Choi YH; Cho SH; Kang HR
    Radiology; 2018 Sep; 288(3):710-716. PubMed ID: 29786483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonionic iodinated contrast media reactions.
    Lasser EC
    AJR Am J Roentgenol; 2009 Feb; 192(2):W80; author reply W81. PubMed ID: 19155387
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of Allergic-like Reactions at Repeat CT: Steroid Pretreatment versus Contrast Material Substitution.
    McDonald JS; Larson NB; Kolbe AB; Hunt CH; Schmitz JJ; Maddox DE; Hartman RP; Kallmes DF; McDonald RJ
    Radiology; 2021 Oct; 301(1):133-140. PubMed ID: 34342504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of Breakthrough Reactions in Inpatients at High Risk Receiving Premedication Before Contrast-Enhanced CT.
    Mervak BM; Davenport MS; Ellis JH; Cohan RH
    AJR Am J Roentgenol; 2015 Jul; 205(1):77-84. PubMed ID: 26102383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology.
    Cohan RH; Ellis JH; Dunnick NR
    Radiology; 1995 Feb; 194(2):357-64. PubMed ID: 7824710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions.
    Wang CL; Cohan RH; Ellis JH; Caoili EM; Wang G; Francis IR
    AJR Am J Roentgenol; 2008 Aug; 191(2):409-15. PubMed ID: 18647910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients.
    Lee SY; Yang MS; Choi YH; Park CM; Park HW; Cho SH; Kang HR
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):339-344.e1. PubMed ID: 28087383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Evidence for and Against Corticosteroid Prophylaxis in At-Risk Patients.
    Davenport MS; Cohan RH
    Radiol Clin North Am; 2017 Mar; 55(2):413-421. PubMed ID: 28126223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactions to iodinated contrast media].
    Porri F; Vervloet D
    Allerg Immunol (Paris); 1994 Dec; 26(10):374-6, 379. PubMed ID: 7702729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of corticosteroid prophylaxis for hypersensitivity reactions to low osmolar contrast media in high-risk patients.
    Jung JW; Choi YH; Park CM; Park HW; Cho SH; Kang HR
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):304-309.e1. PubMed ID: 27613465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile and protocol prevention of adverse reactions to uroangiographic contrast media in diagnostic imaging.
    Rossi C; Reginelli A; D'Amora M; Di Grezia G; Mandato Y; D'Andrea A; Brunese L; Grassi R; Rotondi A
    J Biol Regul Homeost Agents; 2014; 28(1):155-65. PubMed ID: 24750802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication.
    Freed KS; Leder RA; Alexander C; DeLong DM; Kliewer MA
    AJR Am J Roentgenol; 2001 Jun; 176(6):1389-92. PubMed ID: 11373198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of intravenous contrast material use and corticosteroid premedication in children--a survey of Society of Chairs of Radiology in Children's Hospitals (SCORCH) member institutions.
    Trout AT; Dillman JR; Ellis JH; Cohan RH; Strouse PJ
    Pediatr Radiol; 2011 Oct; 41(10):1272-83. PubMed ID: 21594547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe Use of Contrast Media: What the Radiologist Needs to Know.
    Beckett KR; Moriarity AK; Langer JM
    Radiographics; 2015 Oct; 35(6):1738-50. PubMed ID: 26466182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: from published evidence to a practical approach.
    Tonolini M; Bianco R
    Clin Ter; 2011; 162(6):591-4. PubMed ID: 22262334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC; Lyon SG; Berry CC
    Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Corticosteroid Premedication Administered 5 Hours before CT Compared with a Traditional 13-Hour Oral Regimen.
    Mervak BM; Cohan RH; Ellis JH; Khalatbari S; Davenport MS
    Radiology; 2017 Nov; 285(2):425-433. PubMed ID: 28745940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Acute reactions to urographic contrast medium: incidence, clinical characteristics, and relationship to history of hypersensitivity states"--a commentary.
    Katzberg RW
    AJR Am J Roentgenol; 2008 Jun; 190(6):1431-2. PubMed ID: 18492886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.